InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: roctober post# 1603

Saturday, 06/23/2018 10:20:05 AM

Saturday, June 23, 2018 10:20:05 AM

Post# of 2001
Birinapant:

Official Title: A Phase 1/2 Multicenter, Single-Arm, Open-Label, Dose-Escalation Study of Birinapant in Combination With Pembrolizumab (KEYTRUDA®) in Patients With Relapsed or Refractory Solid Tumors


Actual Study Start Date : August 4, 2017
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

https://clinicaltrials.gov/ct2/show/NCT02587962